Epidemiology, Characteristics, and Treatment Outcomes of Mycoplasma pneumoniae Pneumonia in Hospitalized Adults: A 5-Year Retrospective Cohort Study - Top-Institutions - MDSpire

Epidemiology, Characteristics, and Treatment Outcomes of Mycoplasma pneumoniae Pneumonia in Hospitalized Adults: A 5-Year Retrospective Cohort Study

  • By

  • Karl Hagman

  • Anna C Nilsson

  • Magnus Hedenstierna

  • Johan Ursing

  • June 26, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Pulmonology
    • Epidemiology

  • #2

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Pulmonology
    • Clinical Epidemiology

  • #3

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Sweden

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Pulmonology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Pulmonology
    • Infectious Diseases
    • Clinical Research

  • #5

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Pulmonology
    • Clinical Epidemiology

Original Source(s)

Epidemiology, Characteristics, and Treatment Outcomes of Mycoplasma pneumoniae Pneumonia in Hospitalized Adults: A 5-Year Retrospective Cohort Study

  • by Karl Hagman, Anna C Nilsson, Magnus Hedenstierna, Johan Ursing

  • June 26, 2025

Related Content

Thrombocytosis in Pneumonia Patients: A Marker of Severe Inflammation and Variable Mortality Risk

Case Report: Beyond conventional diagnostics: mNGS support in a complex immunocompromised patient diagnosis

Omadacycline for Pediatric CAP

Case details intravenous-to-oral strategy after multiple antibiotic hypersensitivity reactions